Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: stimulant drugs (Click to remove) Diagnosis and Treatment of Tourette Syndrome Neurol 87:e65-e67, Hirschtritt, M.E.,et al, 2016 Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Amphetamines and Related Agents Adams & Victors Principles of Neurology Chp 43, pg 1213, Ropper, A.H.,et al, 2014 Adult Attention Deficit - Hyperactivity Disorder NEJM 369:1935-1944, Volkow, N.D. & Swanson, J.M., 2013 Clinicopathologic Conference, Methcathinone (Bath Salts) Intoxication NEJM 369:2536-2545, Case 40-2013, 2013 A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese NEJM 358:1009-1017, Stepens,A.,et al, 2008 Narcolepsy With Cataplexy Lancet 369:499-511, Dauvilliers,Y.,et al, 2007 Attention-deficit Hyperactivity Disorder Lancet 366:237-248, Biederman,J. &Faraone,S., 2005 Attention-Deficit/Hyperactivity Disorder in Adults JAMA 292:619-623, Wilens,T.E.,et al, 2004 Evidence Based Management of Attention Deficit Hyperactivity Disorder BMJ 323:1232-1235, Guevara,J.P. &Stein,M.T., 2001 Problems in the Management of Attention-Deficit-Hyperactivity Disorder NEJM 340:40-46, Zametkin,A.J.&Ernst,M., 1999 Treatment of Attention-Deficit-Hyperactivity Disorder NEJM 340:780-788, Elia,J.,et al, 1999 Attention-Deficit Hyperactivity Disorder and Hyperkinetic Disorder Lancet 351:429-433, 3871998., Swanson,J.M.,et al, 1998 Toxicity and Deaths from 3, 4-Methylenedioxymethamphetamine ("ecstast") Lancet 340:384-387, Henry,J.A.,et al, 1992 Showing articles 0 to 13 of 13